It is concluded that Sac(+) cell tumours will resist the strong immune defence mechanisms they induce and grow progressively, if the inoculated cells are able to build up a solid, poorly vascularized nodule in the tissue. This always happens after implantation of 106 cells, but only occasionally when fewer cells are inoculated. Sac-virus-induced tumours will always regress owing to the strong immune response. The regression is furthered by the fact that M SV-M infection rarely if ever leads to a stable transformation.
EXTENSIVE STUDlES on the mechanism genicity of murine sarcoma virus (MSV) of regression of tumours induced in mice may be the reason that regression occurs by murine Moloney sarcoma virus in MSV-induced local tumours (Herber-(MSV-M) (Levy & Leclerc, 1977) were man, 1977). mainly (if not exclusively) focused on There is no doubt that regression of immunological parameters accompanying MSV-M-induced tumours is the consetumour development and regression. Re-quence of a sequence of immunological sults of these studies led to the assumption events during tumour development. In that the particularly strong immuno-immunoincompetent tumour-bearers there is no regression (Fefer et al., 1967; Collavo et al., 1976; Stutman, 1975;  Davis, 1975) ; tumours grow progressively and lead to the death of their hosts.
Transformation by the usually used original strain of MSV-M obviously does not lead to cells with the capacity for sustained division (Bather et al., 1968) . This peculiarity has to our knowledge not been considered as an additional prerequisite to a strong immune response for the regularly regressive course of MSV-M-induced tumours.
The aim of the present study was (Weiland & Weiland, 1974; Weiland & Mussgay, 1975 . STU mouse embryo fibroblasts (STU-MEF) were establislied from 17-day-old embryos.
Virus and cells.-The Moloney isolate of MSV (MSV-M) was as used in previous studies (Weiland & Weiland, 1974; Weiland et al., 1978) . It was obtained from Flow Laboratories Inc. (Rockville, Md.), Code No. MSV-B-62. The origin of the non-producer cell "Sac(-)" from a secondary tumour that developed at the site where a primary MSV-M-induced tumour had regressed was decribed recently (Weiland et al., 1978 (MLV-M) produced by the cell line "Be" led to the sarcoma-and helpervirus-producing cell "Sac(+)" (Weiland et al., 1978) . The (Ting & Bader, 1969; Rowe et al., 1970 Assay for cell-and antibody-mediated cytotoxicity (CMC, AMC) and transplantation protection.-As described in detail in a former study (Weiland et al., 1978) (Weiland et al., 1978 Berman & Allison, 1969; Siegler, 1970 (Fig. lb) reported in a previous communication ur,tinv, nf tra,,n,.qn1,a,,nh7,6,nn (Weiland et al., 1978) . Tables 11,  III and IV. In a previous paper (Weiland et al., 1978) (Ponte'n, 1964) .
Studies with mouse tumours induced by transplantation of stably transformed sarcoma-virus-producing cells on the one hand, and by injection of sarcoma virus alone on the other, may help to answer this question.
Recently, we reported on a non-producer tumour cell (Sac(-)) with rescuable sarcoma-virus genome derived from a recurring MSV-M-induced tumour (Weiland et al., 1978 (Hartley & Rowe, 1966 (Bassin et al., 1970; Aaronson et al., 1972; Peebles et al., 1975) , that contains MSV-M in a greater amount than MLV-M.
Though it is possible experimentally to obtain stably MSV-M-transformed mouse cells, it seems to be a rare event (Bassin et al., 1970) . The ratio of MSV-M-induced foci to soft-agar-colony-forming units was in excess of 1000 to 1, compared to a ratio of 50 to I obtained with the B-34 virus derived from MSV-Harvey-induced hamster tumour cells (Zavada & Macpherson, 1970 
